Back to search

University of Leeds

Fungi in the Lungs of People with Cystic Fibrosis: Immune Response and The Airway Mycobiome

Abstract

dc:description.abstract

Cystic fibrosis (CF) is a genetic disease affecting multiple body organs; however, pulmonary complications remain the most common cause of morbidity and mortality. An increasing body of evidence has linked fungi to worsening CF disease, but their role has not been fully explored, partly due to challenges associated with diagnosis. The aim of this thesis was to better understand the role of immune response in the diagnosis of Aspergillus related diseases and to gain a full picture of fungi found in CF airways - the mycobiome, and how it relates to clinical conditions and treatments. Three studies were performed. First, serum samples were analysed from CF patients with Allergic Bronchopulmonary Aspergillosis (ABPA), Aspergillus sensitisation, and Aspergillus bronchitis for their IgE and IgG response to Aspergillus recombinant antigens. Second, 126 CF patients were recruited, and their sputum samples were analysed by conventional culture methods and next generation sequencing comparing two internal transcribed sequence ribosomal DNA regions to assess the mycobiome. In a subset of patients, lung mycobiome was investigated in relation to lung disease severity as well as CFTR modulator therapy. Third, the impact of antifungals on the lung mycobiome was investigated in a longitudinal study where sputum samples from before and during/post treatment were analysed. Asp f1 and f2 antigens were associated with Aspergillus bronchitis, with Asp f1 in particular was significantly linked to culture positivity. Patients with ABPA showed a more heterogeneous response ranging from allergy to infection like presentation. The mycobiome analysis revealed more fungi than conventional methods. Amplification of ITS2 rDNA provided better detection of Aspergillus and Exophiala species. However, fungal burden seems to decline in patients with severe lung disease and in those on CFTR modulators. In patients receiving antifungal therapy, the lung mycobiome remains largely stable.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Alghamdi, Nada Saeed A
Advisors dc:contributor.advisor
  • Peckham, Daniel
  • Barton, Richard
  • Mitra, Suparna
  • Wilcox, Mark
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Alghamdi, Nada Saeed A. Fungi in the Lungs of People with Cystic Fibrosis: Immune Response and The Airway Mycobiome. doctoral thesis, University of Leeds, 2021.